HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francesca Fazioli Selected Research

Neoplasms (Cancer)

5/2021Prognostic Relevance of Macrophage Phenotypes in High-grade Oral Tongue Squamous Cell Carcinomas.
1/2013Circulating inflamma-miRs in aging and age-related diseases.
3/2009Increased urokinase-type plasminogen activator receptor and epidermal growth factor receptor in serum of patients with prostate cancer.
8/2008Prognostic value analysis of urokinase-type plasminogen activator receptor in oral squamous cell carcinoma: an immunohistochemical study.
7/2008A new germline point mutation in Ret exon 8 (cys515ser) in a family with medullary thyroid carcinoma.
9/2005Activation of alpha-diacylglycerol kinase is critical for the mitogenic properties of anaplastic lymphoma kinase.
5/2005Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours.
2/2004Immunohistochemical evaluation of urokinase plasminogen activator receptor in noninvasive and early invasive urothelial papillary neoplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Francesca Fazioli Research Topics

Disease

8Neoplasms (Cancer)
05/2021 - 02/2004
2Alzheimer Disease (Alzheimer's Disease)
01/2021 - 01/2013
2Type 2 Diabetes Mellitus (MODY)
01/2021 - 01/2013
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
09/2005 - 06/2002
1Cognitive Dysfunction
01/2021
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021
1Disease Progression
01/2021
1Body Weight (Weight, Body)
10/2015
1Weight Loss (Weight Reduction)
10/2015
1Rheumatoid Arthritis
01/2013
1Cardiovascular Diseases (Cardiovascular Disease)
01/2013
1Inflammation (Inflammations)
01/2013
1Adenocarcinoma
03/2009
1Prostatic Neoplasms (Prostate Cancer)
03/2009
1Margins of Excision
03/2009
1Squamous Cell Carcinoma of Head and Neck
08/2008
1Neoplasm Metastasis (Metastasis)
08/2008
1Carcinoma (Carcinomatosis)
05/2005
1Adenoma (Adenomas)
05/2005
1Papilloma (Papillomatosis)
02/2004
1Papillary Carcinoma
02/2004

Drug/Important Bio-Agent (IBA)

3Biomarkers (Surrogate Marker)IBA
01/2021 - 08/2008
3Urokinase Plasminogen Activator ReceptorsIBA
03/2009 - 02/2004
2MicroRNAs (MicroRNA)IBA
01/2021 - 01/2013
2Anaplastic Lymphoma KinaseIBA
09/2005 - 06/2002
1CD163 antigenIBA
05/2021
1CD11c AntigenIBA
05/2021
1InterleukinsIBA
01/2021
1Tyrosine (L-Tyrosine)FDA Link
10/2015
1LeptinIBA
10/2015
1Ciliary Neurotrophic Factor (CNTF)IBA
10/2015
1Prostate-Specific Antigen (Semenogelase)IBA
03/2009
1ErbB Receptors (EGF Receptor)IBA
03/2009
1Enzyme Precursors (Zymogens)IBA
08/2008
1Chemotactic FactorsIBA
08/2008
1DisulfidesIBA
07/2008
1LigandsIBA
07/2008
1Diacylglycerol KinaseIBA
09/2005
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
09/2005
1p80(NPM-ALK) proteinIBA
09/2005
1Messenger RNA (mRNA)IBA
05/2005
1somatotropin releasing hormone receptorIBA
05/2005
1Insulin-Like Growth Factor II (Somatomedin A)IBA
05/2005
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
06/2002

Therapy/Procedure

1Intraperitoneal Injections
10/2015
1Prostatectomy (Retropubic Prostatectomy)
03/2009
1Therapeutics
08/2008